Status:

RECRUITING

Aerobic vs Resistance Exercise in Post-menopausal Women With Type 1 Diabetes

Lead Sponsor:

University of Alberta

Collaborating Sponsors:

Women and Children's Health Research Institute, Canada

Conditions:

Type 1 Diabetes

Post-menopause

Eligibility:

FEMALE

45-75 years

Phase:

NA

Brief Summary

Participants will be asked to wear a continuous glucose monitor for at least three days on three separate occasions. One testing session will be a no-exercise resting control session (90 minutes). One...

Detailed Description

Pre-test measures: Interested participants will be invited to either the Exercise Physiology laboratory the Augustana campus of the University of Alberta, or the Physical Activity and Diabetes Laborat...

Eligibility Criteria

Inclusion

  • type 1 diabetes, diagnosed for at least one year
  • post-menopause (at least one year since last menstrual period), or have had a hysterectomy and bilateral salpingo oophorectomy
  • able to perform aerobic and resistance exercise
  • able to visit the lab in Edmonton, Alberta (University of Alberta)

Exclusion

  • HbA1c \> 9.9 %
  • frequent and unpredictable hypoglycemia
  • change in insulin management strategy within the last 2 months
  • blood pressure \> 140 / 95
  • severe peripheral neuropathy
  • history of cardiovascular disease
  • musculoskeletal injuries interfering with exercise performance
  • use of medications (other than insulin) that affect glucose metabolism
  • BMI \> 30 kg/m2
  • smoking
  • moderate to high alcohol intake (\> 2 drinks/day)

Key Trial Info

Start Date :

November 16 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2025

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05188027

Start Date

November 16 2021

End Date

December 30 2025

Last Update

February 5 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Alberta Diabetes Institute

Edmonton, Alberta, Canada, T6G 2R3

2

Institut de recherches cliniques de Montréal

Montreal, Quebec, Canada, H2W 1R7